Practice Guideline
doi: 10.6004/jnccn.2017.0050.
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
- PMID: 28404761
- DOI: 10.6004/jnccn.2017.0050
Item in Clipboard
Practice Guideline
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
J Natl Compr Canc Netw.
2017 Apr.
Abstract
This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastatic disease. For example, new recommendations were added for atezolizumab, ceritinib, osimertinib, and pembrolizumab for the 2017 updates.
Copyright © 2017 by the National Comprehensive Cancer Network.
Similar articles
-
NCCN Guidelines Updates: New Immunotherapy Strategies for Improving Outcomes in Non-Small Cell Lung Cancer.J Natl Compr Canc Netw. 2019 May 1;17(5.5):574-578. doi: 10.6004/jnccn.2019.5005. J Natl Compr Canc Netw. 2019. PMID: 31117034
-
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw. 2022 May;20(5):497-530. doi: 10.6004/jnccn.2022.0025. J Natl Compr Canc Netw. 2022. Update in: J Natl Compr Canc Netw. 2024 May;22(4):249-274. doi: 10.6004/jnccn.2204.0023. PMID: 35545176 Updated.
-
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.J Natl Compr Canc Netw. 2021 Mar 2;19(3):254-266. doi: 10.6004/jnccn.2021.0013. J Natl Compr Canc Netw. 2021. PMID: 33668021
-
Updates in Local-Regionally Advanced Non-Small Cell Lung Cancer.Am Soc Clin Oncol Educ Book. 2019 Jan;39:553-562. doi: 10.1200/EDBK_237839. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099691 Review.
-
First-line immune checkpoint blockade for advanced non-small-cell lung cancer: Travelling at the speed of light.Lung Cancer. 2019 Aug;134:245-253. doi: 10.1016/j.lungcan.2019.06.007. Epub 2019 Jun 19. Lung Cancer. 2019. PMID: 31319988 Review.
Cited by
-
Perspectives and controversies regarding the use of natural products for the treatment of lung cancer.Cancer Med. 2021 Apr;10(7):2396-2422. doi: 10.1002/cam4.3660. Epub 2021 Mar 2. Cancer Med. 2021. PMID: 33650320 Free PMC article. Review.
-
Recent advances in postoperative pulmonary rehabilitation of patients with non‑small cell lung cancer (Review).Int J Oncol. 2022 Dec;61(6):156. doi: 10.3892/ijo.2022.5446. Epub 2022 Nov 2. Int J Oncol. 2022. PMID: 36321778 Free PMC article. Review.
-
Osimertinib versus platinum-pemetrexed in patients with previously treated EGFR T790M advanced non-small cell lung cancer: An updated AURA3 trial-based cost-effectiveness analysis.Front Oncol. 2022 Oct 17;12:833773. doi: 10.3389/fonc.2022.833773. eCollection 2022. Front Oncol. 2022. PMID: 36324594 Free PMC article.
-
Comparative efficacy of various CHIs combined with western medicine for non-small cell lung cancer: A bayesian network meta-analysis of randomized controlled trials.Front Pharmacol. 2022 Nov 10;13:1037620. doi: 10.3389/fphar.2022.1037620. eCollection 2022. Front Pharmacol. 2022. PMID: 36438813 Free PMC article.
-
Relationship between nausea and vomiting and physical activity in patients with lung cancer undergoing first chemotherapy.Front Oncol. 2024 Jul 24;14:1396637. doi: 10.3389/fonc.2024.1396637. eCollection 2024. Front Oncol. 2024. PMID: 39114312 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
